Curis Lifesciences
NSE SME₹2,56,000 / Individual : 2000 Shares
IPO Live Subscription Details
| Category | Subscription (Times) |
|---|---|
| Date | 11 Nov 2025, 06:55 PM |
| QIBs | 96.17 times |
| NII | 115.81 times |
| Total | 74.47 times |
Curis Lifesciences IPO Details
The Curis Lifesciences IPO price band is set between ₹120-128 per equity share, with a face value of ₹10 per share. The issue is managed by MUFG Intime India Pvt.Ltd., and the equity shares are proposed to be listed on the NSE SME.
The IPO date for subscription opens on 7 Nov, 2025 and closes on 11 Nov, 2025. Investors can check the allotment status on 12 Nov, 2025, while the listing date is tentatively scheduled for 14 Nov, 2025.
The total issue size is 21,50,000 shares, aggregating up to ₹27.52 crore. Stay tuned for the latest Curis Lifesciences IPO review and GMP updates.
Curis Lifesciences IPO Review, Rating & Analysis
Curis Lifesciences IPO Review
IgnoreCuris Lifesciences IPO Rating
Curis Lifesciences IPO Highlights
IPO Date
Nov 7, 2025 - Nov 11, 2025
Listing Date
14 Nov, 2025
Face Value
₹10 Per Equity Share
Price Band
₹120-128 per equity share
Lot Size
-
Fresh Issue
Shares
Offer for Sale
-
Listing At
NSE SME
Curis Lifesciences IPO Lot Size
The minimum market lot for Curis Lifesciences IPO is 2000 shares with an application amount of ₹2,56,000. Retail investors can apply for up to 0 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹2,56,000 |
| Retail (Max) | 0 | 0 | ₹0 |
| S-HNI (Min) | 1 | 2000 | ₹2,56,000 |
| S-HNI (Max) | 3 | 6000 | ₹7,68,000 |
| B-HNI (Min) | 4 | 8000 | ₹10,24,000 |
Curis Lifesciences IPO Timeline
Issue Price
₹120-128 per equity shareFace Value
₹10 Per Equity ShareListing at Group
NSE SMERegistrar
MUFG Intime India Pvt.Ltd.Lead Manager
Finaax Capital Advisors Private LimitedIssue Size
21,50,000 shares(aggregating up to ₹27.52 crore)Curis Lifesciences IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31-Dec-24 | 50.12 | 36.91 | 5.30 | 15.53 | 9.59 | 16.16 |
| 31-Mar-24 | 33.82 | 35.89 | 5.03 | 5.97 | 5.47 | 17.09 |
| 31-Mar-23 | 29.67 | 36.39 | 1.85 | 0.95 | 0.45 | 16.19 |
| 31-Mar-22 | 27.40 | 23.76 | 0.49 | 0.90 | -1.40 | 17.62 |
In Cr.
Curis Lifesciences IPO Documents
Curis Lifesciences IPO Valuations
EPS Pre IPO
₹10.29/-EPS Post IPO
₹10.66/-PE Pre IPO
12.44PE Post IPO
12.01ROE
55.25%ROCE
27.83%Debt Equity
0.96RoNW
37.62%PAT Margin
12.43%Price to Book Value
12.64Promoters & Share Holding
Promoter(s) Name
- Mr. Dharmesh Dashrathbhai Patel
- Mr. Siddhant Jayantibhai Pawasia
- Mr. Piyush Gordhanbhai Antala
- Mr. Jaimik Mansukhbhai Patel
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 92.68% | 68.03% |
About Company
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products.
The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya.
Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include:
General pharmaceutical tablets and capsules
Oral liquids
External preparations
Sterile ophthalmic ointments
The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
Curis Lifesciences IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 4,09,000 / 3,08,000 | <span>
7,16,000
</span> | 14,33,000 | |
Day 107-11-25 06:00 PM | 8.34 / 1.19 x | <span>
0.87
x
</span> | 3.07 x | |
Day 210-11-25 06:00 PM | 8.34 / 4.06 x | <span>
3.80
x
</span> | 5.15 x | |
Day 311-11-25 06:00 PM | 96.17 / 115.81 x | <span>
44.28
x
</span> | 74.47 x |
Curis Lifesciences IPO - Issue Objectives & Utilisation of proceeds
| Objectives | Amount |
|---|---|
| Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities | - |
| Capital Expenditure towards Construction of a Storage Facility | - |
| Pre-payment/Repayment of outstanding Secured Loans | - |
| Product Registrations in other countries | - |
| Funding our Working Capital Requirements | - |
| General Corporate Purposes | - |
Company Contact Details
Curis Lifesciences
PF-23, GIDC Sanand - II, Industrial Estate, Sanand, Ahmedabad, Gujarat, 382110Registrar Contact Details
MUFG Intime India Private Limited (Link Intime)
Phone: +91-22-4918 6270
Email: curislifesciences.smeipo@linkintime.co.in
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
Frequently Asked Questions about Curis Lifesciences IPO
When will Curis Lifesciences IPO open for subscription?
The Curis Lifesciences IPO opens on 7 Nov, 2025 and closes on 11 Nov, 2025.
What is the investors portion for Curis Lifesciences IPO?
The investors' portion for QIB is 96.17 115.81 x, NII is 44.28 x, and Retail is .
How to apply for Curis Lifesciences IPO?
You can apply for Curis Lifesciences IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Curis Lifesciences IPO?
The issue size of Curis Lifesciences IPO is approx ₹21,50,000 shares(aggregating up to ₹27.52 crore) crores.
What is the price band of Curis Lifesciences IPO?
The price band for Curis Lifesciences IPO is ₹120 to ₹128 per equity share.
What is the lot size of Curis Lifesciences IPO?
The minimum bid (lot size) for Curis Lifesciences IPO is 1000 shares with an investment of approx ₹2,56,000 .
What is the allotment date of Curis Lifesciences IPO?
The allotment date for Curis Lifesciences IPO is 12 Nov, 2025.
What is the listing date of Curis Lifesciences IPO?
The listing date for Curis Lifesciences IPO is expected to be 14 Nov, 2025.
What is the GMP of Curis Lifesciences IPO?
The latest Grey Market Premium (GMP) for Curis Lifesciences IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.